Trend and pattern of melioidosis seropositivity among suspected patients in Malaysia 2015 - 2019

F S Hadi1, S Ghazali2, N Ahmad1

  • 1Bacteriology Unit, Infectious Disease Research Centre, Institute for Medical Research, National Institutes of Health, Ministry of Health Malaysia, Setia Alam, 40170, Shah Alam, Selangor, Malaysia.

Tropical Biomedicine
|January 10, 2022
PubMed

Insights

Melioidosis seropositivity was 16.4% in Malaysian patients. Younger individuals and those with chronic lung disease showed higher susceptibility to this serious Burkholderia pseudomallei infection.

Area of Science:

  • Infectious Diseases
  • Bacteriology
  • Public Health Microbiology

Background:

  • Melioidosis, caused by Burkholderia pseudomallei, is a significant public health concern with high mortality in humans and animals.
  • The bacterium thrives in tropical soil environments, posing a constant threat in endemic regions.

Purpose of the Study:

  • To determine the seropositivity rate of melioidosis among patients in Malaysian healthcare centers between 2015 and 2019.
  • To identify demographic and clinical factors associated with melioidosis seropositivity in Malaysia.

Main Methods:

  • Analysis of 26,665 serum samples from patients suspected of melioidosis in Malaysian hospitals.
  • Testing for IgM antibodies against Burkholderia pseudomallei.
  • Statistical analysis to identify risk factors, including age and pre-existing conditions.

Main Results:

  • Overall seropositivity for melioidosis was 16.4%.
  • Individuals aged under 15 years exhibited the highest susceptibility (AOR 3.04).
  • Chronic lung disease significantly increased susceptibility (adjusted OR: 4.03).
  • Sarawak reported the highest infection rates (15.1%), while Perlis had the lowest (0.9%).

Conclusions:

  • Serological testing, while not a gold standard, is valuable for melioidosis surveillance and monitoring treatment.
  • Identifying high-risk groups, such as the young and those with chronic lung disease, is crucial for targeted prevention.
  • Understanding regional variations in seropositivity aids in focusing public health interventions in endemic hotspots.